119610 — Interojo Co Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedMicro Cap

Annual income statement for Interojo Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	R2023 December 31st	2024 December 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	Annual Audited Accounts	ARS/A	ARS/A	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	88,203	107,535	117,822	119,297	115,840
Cost of Revenue
Gross Profit	44,520	51,935	53,571	36,624	35,543
Selling / General / Administrative Expenses
Research And Development
Depreciation and Amortization
Unusual Expense / Income
Total Operating Expenses	73,302	84,894	93,649	114,105	111,358
Operating Profit	14,901	22,641	24,174	5,192	4,482
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	15,111	21,116	21,611	3,035	1,707
Provision for Income Taxes
Net Income After Taxes	11,543	14,720	18,622	3,147	180
Minority Interest
Net Income Before Extraordinary Items
Net Income	11,543	14,744	18,644	3,159	184
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	11,962	15,151	19,049	3,159	184
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	933	1,193	1,469	253	100
Dividends per Share